Essential Biomarker Testing in GI Cancers

Decera Clinical Education Oncology Podcast · Aug 18, 2021 · 17m

In this episode, John L. Marshall, MD, discusses current molecular testing considerations in the treatment of patients with gastrointestinal tumors, including:

Current testing approaches, including IHC and PD-L1 assays and next-generation sequencing

Tumor agnostic testing: MSI, TMB, and NTRK fusion testing

Colon cancer: RAS, BRAF, and HER2

Gastric cancer: PD-L1, HER2, and more

Pancreatic cancer: BRCA

Biliary cancers: FGFR and IDH1

Liquid biopsies

When to test

Presenter:

John L. Marshall, MD

Chief, Division of Hematology/Oncology

Department of Medicine

Georgetown University Hospital…